http://www.acorda.com
Acorda Therapeutics, Inc. Company Intro
Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis
Industry
Healthcare
Acorda Therapeutics, Inc. Headquaters
420 Saw Mill River Road
Ardsley,10502
United States
Acorda Therapeutics, Inc. Share price
17 May 2023 12:43 GMT
$0.6270
-0.0 (-0.25 %)
Acorda Therapeutics, Inc. Market cap
$23.837 M
WMC RANKING
2023
Acorda Therapeutics, Inc. # 50
BiotechnologyLatest Acorda Therapeutics, Inc. News
29 Nov 2023
Spinal Cord Injury Pipeline Insights Report 2023 (Updated)
Press release - DelveInsight Business Research LLP - Spinal Cord Injury Pipeline Insights Report 2023 (Updated) - published on openPR.com.
29 Nov 2023
Medical Flexible Packaging Market Is Forecast to Surpass ...
Catalent Inc. signed an agreement with Acorda Therapeutics Inc. in 2021, wherein Catalent will acquire Acorda's facility in Chelsea. This acquisition will...
28 Nov 2023
Acorda Therapeutics (NASDAQ:ACOR) Research Coverage Started at StockNews.com
Read Acorda Therapeutics (NASDAQ:ACOR) Research Coverage Started at StockNews.com at Defense World.
WMC Market Score
WMC Market to Revenue Score
Acorda Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Acorda Therapeutics, Inc. | USD | $153,730 | $196,255 | $-126,573 | $238M | 50 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Acorda Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Acorda Therapeutics, Inc. Post vs Top 4 Industry Competitors
Acorda Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Acorda Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Acorda Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Acorda Therapeutics, Inc. | 1.67 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
